Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Fenofibrate 130 mg Capsules in Healthy Male Subjects
NCT02306889Phase 1Completed
- Sponsor
- Ranbaxy Laboratories
- Start
- Jan 2010
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of fenofibrate in hypercholesterolemia (2 arms), sponsored by Ranbaxy Laboratories. Primary endpoints: Area Under the Curve and Peak Plasma Concentration. Started Jan 2010; status: completed.
02
Drugs
fenofibrate
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02306889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306889.